Dr. Reddy’s Laboratories announced that Brazil’s National Health Surveillance Agency (ANVISA) has granted marketing ...
Phatebo sources the comparator, investigational and ancillary medicines that pharmaceutical sponsors and clinical research organisations need to run their trials, and becomes HRV’s first finished form ...
The expansion will add 10 KL of SPPS reactor capacity and establish six parallel cGMP manufacturing lines to support peptide ...
The sectors recorded 19 funding rounds during the month, with funding rising 6.91 per cent year on year and falling 7.35 per ...
Lupin has announced the launch of Raltegravir Tablets USP, 600 mg in the United States, following approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA ...
Under the existing agreement, injectable lenacapavir will be available at US$40 per person per year across 120 countries covered by Gilead’s voluntary licence.
The appointment brings over four decades of experience in business development, corporate strategy, finance, governance and mergers and acquisitions to the Board ...
The agreement with Janssen Sciences Ireland enables commercialisation of the proposed Stelara biosimilar in Australia, Brazil ...
Contract follows successful Process Development and scale-up of a new product, marking a key commercial milestone for ...
The certification follows inspections by Brazil’s ANVISA and Japan’s PMDA, supporting Hikal’s expansion across regulated ...
AIIA-iCAINE launches an IPR facility, signs two MoUs with the World Ayurveda Foundation and Reliance Retail, and conducts a ...
The projects will focus on investigational therapies for advanced keratopathy and wet age-related macular degeneration, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results